nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2D6—Hydroxyurea—head and neck cancer	0.334	0.447	CbGbCtD
Moclobemide—CYP1A2—Fluorouracil—head and neck cancer	0.155	0.207	CbGbCtD
Moclobemide—CYP2C9—Fluorouracil—head and neck cancer	0.139	0.187	CbGbCtD
Moclobemide—CYP2D6—Vinblastine—head and neck cancer	0.118	0.158	CbGbCtD
Moclobemide—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.00948	0.0487	CcSEcCtD
Moclobemide—Photopsia—Docetaxel—head and neck cancer	0.00814	0.0418	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00527	0.0271	CcSEcCtD
Moclobemide—Heartburn—Fluorouracil—head and neck cancer	0.00521	0.0268	CcSEcCtD
Moclobemide—Bezafibrate—CYP1A1—head and neck cancer	0.00519	0.607	CrCbGaD
Moclobemide—Disorientation—Hydroxyurea—head and neck cancer	0.00404	0.0208	CcSEcCtD
Moclobemide—Dysarthria—Fluorouracil—head and neck cancer	0.00379	0.0195	CcSEcCtD
Moclobemide—Heartburn—Docetaxel—head and neck cancer	0.00376	0.0193	CcSEcCtD
Moclobemide—Dermatitis atopic—Docetaxel—head and neck cancer	0.0035	0.018	CcSEcCtD
Moclobemide—Haloperidol—CYP1A1—head and neck cancer	0.00336	0.393	CrCbGaD
Moclobemide—Angina pectoris—Vinblastine—head and neck cancer	0.00334	0.0172	CcSEcCtD
Moclobemide—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00316	0.0623	CbGpPWpGaD
Moclobemide—Dysuria—Hydroxyurea—head and neck cancer	0.00292	0.015	CcSEcCtD
Moclobemide—Disorientation—Fluorouracil—head and neck cancer	0.00291	0.015	CcSEcCtD
Moclobemide—Drowsiness—Hydroxyurea—head and neck cancer	0.00279	0.0143	CcSEcCtD
Moclobemide—Stomatitis—Hydroxyurea—head and neck cancer	0.00272	0.014	CcSEcCtD
Moclobemide—Osteoarthritis—Fluorouracil—head and neck cancer	0.0026	0.0134	CcSEcCtD
Moclobemide—Hallucination—Hydroxyurea—head and neck cancer	0.00249	0.0128	CcSEcCtD
Moclobemide—Irritability—Fluorouracil—head and neck cancer	0.00249	0.0128	CcSEcCtD
Moclobemide—Dry skin—Fluorouracil—head and neck cancer	0.00239	0.0123	CcSEcCtD
Moclobemide—Ill-defined disorder—Vinblastine—head and neck cancer	0.00222	0.0114	CcSEcCtD
Moclobemide—Angina pectoris—Fluorouracil—head and neck cancer	0.00219	0.0113	CcSEcCtD
Moclobemide—Malaise—Vinblastine—head and neck cancer	0.00215	0.0111	CcSEcCtD
Moclobemide—Hypertension—Vinblastine—head and neck cancer	0.00206	0.0106	CcSEcCtD
Moclobemide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00202	0.0104	CcSEcCtD
Moclobemide—Discomfort—Vinblastine—head and neck cancer	0.00201	0.0103	CcSEcCtD
Moclobemide—Hot flush—Docetaxel—head and neck cancer	0.00201	0.0103	CcSEcCtD
Moclobemide—Menopausal symptoms—Docetaxel—head and neck cancer	0.00199	0.0102	CcSEcCtD
Moclobemide—Visual disturbance—Docetaxel—head and neck cancer	0.00198	0.0102	CcSEcCtD
Moclobemide—Malaise—Hydroxyurea—head and neck cancer	0.00196	0.0101	CcSEcCtD
Moclobemide—Stomatitis—Fluorouracil—head and neck cancer	0.00196	0.0101	CcSEcCtD
Moclobemide—Conjunctivitis—Fluorouracil—head and neck cancer	0.00195	0.01	CcSEcCtD
Moclobemide—Migraine—Docetaxel—head and neck cancer	0.00185	0.00951	CcSEcCtD
Moclobemide—Discomfort—Hydroxyurea—head and neck cancer	0.00183	0.00942	CcSEcCtD
Moclobemide—Paraesthesia—Vinblastine—head and neck cancer	0.00175	0.009	CcSEcCtD
Moclobemide—Dry skin—Docetaxel—head and neck cancer	0.00172	0.00885	CcSEcCtD
Moclobemide—Decreased appetite—Vinblastine—head and neck cancer	0.00169	0.00871	CcSEcCtD
Moclobemide—Constipation—Vinblastine—head and neck cancer	0.00167	0.00857	CcSEcCtD
Moclobemide—Feeling abnormal—Vinblastine—head and neck cancer	0.00161	0.00826	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00159	0.00819	CcSEcCtD
Moclobemide—Dyspnoea—Hydroxyurea—head and neck cancer	0.00158	0.00815	CcSEcCtD
Moclobemide—Angina pectoris—Docetaxel—head and neck cancer	0.00158	0.00813	CcSEcCtD
Moclobemide—Somnolence—Hydroxyurea—head and neck cancer	0.00158	0.00812	CcSEcCtD
Moclobemide—Dyspepsia—Hydroxyurea—head and neck cancer	0.00156	0.00804	CcSEcCtD
Moclobemide—Decreased appetite—Hydroxyurea—head and neck cancer	0.00155	0.00794	CcSEcCtD
Moclobemide—Abdominal pain—Vinblastine—head and neck cancer	0.00154	0.00792	CcSEcCtD
Moclobemide—Fatigue—Hydroxyurea—head and neck cancer	0.00153	0.00788	CcSEcCtD
Moclobemide—Constipation—Hydroxyurea—head and neck cancer	0.00152	0.00781	CcSEcCtD
Moclobemide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00151	0.0297	CbGpPWpGaD
Moclobemide—Vision blurred—Fluorouracil—head and neck cancer	0.00148	0.00759	CcSEcCtD
Moclobemide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00147	0.00753	CcSEcCtD
Moclobemide—Stomatitis—Docetaxel—head and neck cancer	0.00141	0.00725	CcSEcCtD
Moclobemide—Conjunctivitis—Docetaxel—head and neck cancer	0.00141	0.00723	CcSEcCtD
Moclobemide—Asthenia—Vinblastine—head and neck cancer	0.0014	0.00719	CcSEcCtD
Moclobemide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00138	0.0272	CbGpPWpGaD
Moclobemide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00138	0.0271	CbGpPWpGaD
Moclobemide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00137	0.0271	CbGpPWpGaD
Moclobemide—Myalgia—Fluorouracil—head and neck cancer	0.00133	0.00686	CcSEcCtD
Moclobemide—Chest pain—Fluorouracil—head and neck cancer	0.00133	0.00686	CcSEcCtD
Moclobemide—Diarrhoea—Vinblastine—head and neck cancer	0.00133	0.00685	CcSEcCtD
Moclobemide—Discomfort—Fluorouracil—head and neck cancer	0.00132	0.00678	CcSEcCtD
Moclobemide—Confusional state—Fluorouracil—head and neck cancer	0.00129	0.00663	CcSEcCtD
Moclobemide—Dizziness—Vinblastine—head and neck cancer	0.00129	0.00663	CcSEcCtD
Moclobemide—Asthenia—Hydroxyurea—head and neck cancer	0.00128	0.00656	CcSEcCtD
Moclobemide—MAOB—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00126	0.0247	CbGpPWpGaD
Moclobemide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00125	0.0247	CbGpPWpGaD
Moclobemide—Visual impairment—Docetaxel—head and neck cancer	0.00125	0.00644	CcSEcCtD
Moclobemide—Tachycardia—Fluorouracil—head and neck cancer	0.00125	0.00642	CcSEcCtD
Moclobemide—Vomiting—Vinblastine—head and neck cancer	0.00124	0.00637	CcSEcCtD
Moclobemide—Headache—Vinblastine—head and neck cancer	0.00122	0.00628	CcSEcCtD
Moclobemide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00122	0.00625	CcSEcCtD
Moclobemide—Flushing—Docetaxel—head and neck cancer	0.00121	0.0062	CcSEcCtD
Moclobemide—Hypotension—Fluorouracil—head and neck cancer	0.0012	0.00615	CcSEcCtD
Moclobemide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00118	0.0232	CbGpPWpGaD
Moclobemide—Dizziness—Hydroxyurea—head and neck cancer	0.00118	0.00604	CcSEcCtD
Moclobemide—MAOA—Oxidative Stress—SOD2—head and neck cancer	0.00117	0.0231	CbGpPWpGaD
Moclobemide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00117	0.00599	CcSEcCtD
Moclobemide—Nausea—Vinblastine—head and neck cancer	0.00116	0.00595	CcSEcCtD
Moclobemide—Insomnia—Fluorouracil—head and neck cancer	0.00116	0.00595	CcSEcCtD
Moclobemide—Paraesthesia—Fluorouracil—head and neck cancer	0.00115	0.00591	CcSEcCtD
Moclobemide—Dyspnoea—Fluorouracil—head and neck cancer	0.00114	0.00586	CcSEcCtD
Moclobemide—MAOA—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00114	0.0224	CbGpPWpGaD
Moclobemide—Somnolence—Fluorouracil—head and neck cancer	0.00114	0.00585	CcSEcCtD
Moclobemide—Vomiting—Hydroxyurea—head and neck cancer	0.00113	0.00581	CcSEcCtD
Moclobemide—Dyspepsia—Fluorouracil—head and neck cancer	0.00113	0.00579	CcSEcCtD
Moclobemide—Rash—Hydroxyurea—head and neck cancer	0.00112	0.00576	CcSEcCtD
Moclobemide—Dermatitis—Hydroxyurea—head and neck cancer	0.00112	0.00576	CcSEcCtD
Moclobemide—MAOA—Oxidative Stress—GPX1—head and neck cancer	0.00112	0.022	CbGpPWpGaD
Moclobemide—Headache—Hydroxyurea—head and neck cancer	0.00111	0.00572	CcSEcCtD
Moclobemide—Decreased appetite—Fluorouracil—head and neck cancer	0.00111	0.00572	CcSEcCtD
Moclobemide—MAOA—Oxidative Stress—CYP1A1—head and neck cancer	0.00111	0.0218	CbGpPWpGaD
Moclobemide—Dysgeusia—Docetaxel—head and neck cancer	0.00111	0.0057	CcSEcCtD
Moclobemide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00107	0.0211	CbGpPWpGaD
Moclobemide—Nausea—Hydroxyurea—head and neck cancer	0.00106	0.00543	CcSEcCtD
Moclobemide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00105	0.00542	CcSEcCtD
Moclobemide—Urticaria—Fluorouracil—head and neck cancer	0.00102	0.00522	CcSEcCtD
Moclobemide—Syncope—Docetaxel—head and neck cancer	0.00101	0.00522	CcSEcCtD
Moclobemide—Palpitations—Docetaxel—head and neck cancer	0.001	0.00514	CcSEcCtD
Moclobemide—Loss of consciousness—Docetaxel—head and neck cancer	0.000995	0.00511	CcSEcCtD
Moclobemide—Hypertension—Docetaxel—head and neck cancer	0.000977	0.00502	CcSEcCtD
Moclobemide—Chest pain—Docetaxel—head and neck cancer	0.000963	0.00495	CcSEcCtD
Moclobemide—Myalgia—Docetaxel—head and neck cancer	0.000963	0.00495	CcSEcCtD
Moclobemide—Dry mouth—Docetaxel—head and neck cancer	0.000942	0.00484	CcSEcCtD
Moclobemide—MAOB—Biological oxidations—NAT2—head and neck cancer	0.000933	0.0184	CbGpPWpGaD
Moclobemide—Confusional state—Docetaxel—head and neck cancer	0.000931	0.00479	CcSEcCtD
Moclobemide—Shock—Docetaxel—head and neck cancer	0.000909	0.00467	CcSEcCtD
Moclobemide—Pruritus—Fluorouracil—head and neck cancer	0.000905	0.00465	CcSEcCtD
Moclobemide—Tachycardia—Docetaxel—head and neck cancer	0.000901	0.00463	CcSEcCtD
Moclobemide—Diarrhoea—Fluorouracil—head and neck cancer	0.000876	0.0045	CcSEcCtD
Moclobemide—Hypotension—Docetaxel—head and neck cancer	0.000863	0.00444	CcSEcCtD
Moclobemide—Dizziness—Fluorouracil—head and neck cancer	0.000846	0.00435	CcSEcCtD
Moclobemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000846	0.0166	CbGpPWpGaD
Moclobemide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000841	0.00432	CcSEcCtD
Moclobemide—Insomnia—Docetaxel—head and neck cancer	0.000835	0.00429	CcSEcCtD
Moclobemide—Paraesthesia—Docetaxel—head and neck cancer	0.000829	0.00426	CcSEcCtD
Moclobemide—Dyspnoea—Docetaxel—head and neck cancer	0.000823	0.00423	CcSEcCtD
Moclobemide—MAOB—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000823	0.0162	CbGpPWpGaD
Moclobemide—Somnolence—Docetaxel—head and neck cancer	0.000821	0.00422	CcSEcCtD
Moclobemide—Vomiting—Fluorouracil—head and neck cancer	0.000814	0.00418	CcSEcCtD
Moclobemide—Dyspepsia—Docetaxel—head and neck cancer	0.000813	0.00418	CcSEcCtD
Moclobemide—Rash—Fluorouracil—head and neck cancer	0.000807	0.00415	CcSEcCtD
Moclobemide—Dermatitis—Fluorouracil—head and neck cancer	0.000806	0.00414	CcSEcCtD
Moclobemide—Decreased appetite—Docetaxel—head and neck cancer	0.000803	0.00413	CcSEcCtD
Moclobemide—Headache—Fluorouracil—head and neck cancer	0.000802	0.00412	CcSEcCtD
Moclobemide—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000798	0.0157	CbGpPWpGaD
Moclobemide—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000798	0.0157	CbGpPWpGaD
Moclobemide—Fatigue—Docetaxel—head and neck cancer	0.000796	0.00409	CcSEcCtD
Moclobemide—Constipation—Docetaxel—head and neck cancer	0.00079	0.00406	CcSEcCtD
Moclobemide—Feeling abnormal—Docetaxel—head and neck cancer	0.000761	0.00391	CcSEcCtD
Moclobemide—Nausea—Fluorouracil—head and neck cancer	0.00076	0.00391	CcSEcCtD
Moclobemide—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000755	0.00388	CcSEcCtD
Moclobemide—Abdominal pain—Docetaxel—head and neck cancer	0.00073	0.00375	CcSEcCtD
Moclobemide—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000726	0.0143	CbGpPWpGaD
Moclobemide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000723	0.0142	CbGpPWpGaD
Moclobemide—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000698	0.0137	CbGpPWpGaD
Moclobemide—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000676	0.0133	CbGpPWpGaD
Moclobemide—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000668	0.0131	CbGpPWpGaD
Moclobemide—Asthenia—Docetaxel—head and neck cancer	0.000663	0.00341	CcSEcCtD
Moclobemide—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000662	0.013	CbGpPWpGaD
Moclobemide—Pruritus—Docetaxel—head and neck cancer	0.000653	0.00336	CcSEcCtD
Moclobemide—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000649	0.0128	CbGpPWpGaD
Moclobemide—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000642	0.0126	CbGpPWpGaD
Moclobemide—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000636	0.0125	CbGpPWpGaD
Moclobemide—Diarrhoea—Docetaxel—head and neck cancer	0.000632	0.00325	CcSEcCtD
Moclobemide—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000615	0.0121	CbGpPWpGaD
Moclobemide—Dizziness—Docetaxel—head and neck cancer	0.000611	0.00314	CcSEcCtD
Moclobemide—Vomiting—Docetaxel—head and neck cancer	0.000587	0.00302	CcSEcCtD
Moclobemide—MAOA—Biological oxidations—NAT2—head and neck cancer	0.000586	0.0115	CbGpPWpGaD
Moclobemide—Rash—Docetaxel—head and neck cancer	0.000582	0.00299	CcSEcCtD
Moclobemide—Dermatitis—Docetaxel—head and neck cancer	0.000582	0.00299	CcSEcCtD
Moclobemide—Headache—Docetaxel—head and neck cancer	0.000579	0.00297	CcSEcCtD
Moclobemide—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000566	0.0111	CbGpPWpGaD
Moclobemide—Nausea—Docetaxel—head and neck cancer	0.000549	0.00282	CcSEcCtD
Moclobemide—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000544	0.0107	CbGpPWpGaD
Moclobemide—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000539	0.0106	CbGpPWpGaD
Moclobemide—MAOA—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000516	0.0102	CbGpPWpGaD
Moclobemide—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000496	0.00976	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—GSTM1—head and neck cancer	0.000461	0.00907	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—CYP1A1—head and neck cancer	0.000437	0.0086	CbGpPWpGaD
Moclobemide—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00042	0.00827	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—UROD—head and neck cancer	0.000384	0.00756	CbGpPWpGaD
Moclobemide—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00037	0.00729	CbGpPWpGaD
Moclobemide—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000369	0.00727	CbGpPWpGaD
Moclobemide—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000352	0.00693	CbGpPWpGaD
Moclobemide—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000349	0.00686	CbGpPWpGaD
Moclobemide—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000321	0.00632	CbGpPWpGaD
Moclobemide—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000318	0.00626	CbGpPWpGaD
Moclobemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000301	0.00593	CbGpPWpGaD
Moclobemide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000297	0.00585	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00029	0.00572	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00029	0.00572	CbGpPWpGaD
Moclobemide—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00029	0.00572	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—GSTM1—head and neck cancer	0.000289	0.00569	CbGpPWpGaD
Moclobemide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000277	0.00545	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000277	0.00545	CbGpPWpGaD
Moclobemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000275	0.00541	CbGpPWpGaD
Moclobemide—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000274	0.0054	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—CYP1A1—head and neck cancer	0.000274	0.0054	CbGpPWpGaD
Moclobemide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000274	0.00538	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000273	0.00538	CbGpPWpGaD
Moclobemide—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000272	0.00535	CbGpPWpGaD
Moclobemide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000271	0.00534	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000255	0.00502	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000253	0.00497	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000251	0.00495	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000249	0.00491	CbGpPWpGaD
Moclobemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000244	0.00481	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—UROD—head and neck cancer	0.000241	0.00475	CbGpPWpGaD
Moclobemide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000235	0.00462	CbGpPWpGaD
Moclobemide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000232	0.00456	CbGpPWpGaD
Moclobemide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000225	0.00442	CbGpPWpGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000223	0.00438	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000216	0.00425	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000213	0.00419	CbGpPWpGaD
Moclobemide—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000207	0.00408	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00019	0.00375	CbGpPWpGaD
Moclobemide—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000189	0.00372	CbGpPWpGaD
Moclobemide—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000182	0.00359	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000173	0.0034	CbGpPWpGaD
Moclobemide—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000162	0.00318	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00016	0.00315	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NAT2—head and neck cancer	0.00016	0.00314	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—DPYD—head and neck cancer	0.00014	0.00275	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000139	0.00273	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000137	0.00269	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000136	0.00268	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000135	0.00266	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—YAP1—head and neck cancer	0.000133	0.00261	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.00013	0.00255	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000128	0.00252	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000126	0.00248	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000125	0.00246	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000124	0.00244	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000123	0.00242	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000122	0.00241	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000122	0.00241	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000122	0.00241	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000119	0.00235	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000118	0.00233	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000118	0.00232	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000117	0.0023	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—UROD—head and neck cancer	0.000114	0.00225	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000107	0.0021	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000105	0.00207	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—UROD—head and neck cancer	0.000105	0.00207	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—UROD—head and neck cancer	0.000104	0.00205	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000102	0.00202	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000101	0.00199	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NAT2—head and neck cancer	0.0001	0.00197	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	9.97e-05	0.00196	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	9.83e-05	0.00193	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—UROD—head and neck cancer	8.9e-05	0.00175	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.86e-05	0.00174	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—DPYD—head and neck cancer	8.78e-05	0.00173	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—YAP1—head and neck cancer	8.33e-05	0.00164	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	8.23e-05	0.00162	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.08e-05	0.00159	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TYMS—head and neck cancer	7.97e-05	0.00157	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTM1—head and neck cancer	7.88e-05	0.00155	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—MAPK1—head and neck cancer	7.85e-05	0.00154	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GPX1—head and neck cancer	7.55e-05	0.00149	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP1A1—head and neck cancer	7.47e-05	0.00147	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.9e-05	0.00136	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—HRAS—head and neck cancer	6.3e-05	0.00124	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.03e-05	0.000991	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TYMS—head and neck cancer	5e-05	0.000985	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.98e-05	0.000981	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTM1—head and neck cancer	4.95e-05	0.000973	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NAT2—head and neck cancer	4.74e-05	0.000933	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GPX1—head and neck cancer	4.74e-05	0.000932	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP1A1—head and neck cancer	4.69e-05	0.000923	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.59e-05	0.000903	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.54e-05	0.000894	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—head and neck cancer	4.44e-05	0.000875	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NAT2—head and neck cancer	4.36e-05	0.000858	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NAT2—head and neck cancer	4.32e-05	0.000851	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—DPYD—head and neck cancer	4.16e-05	0.000818	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—YAP1—head and neck cancer	3.94e-05	0.000776	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.92e-05	0.000772	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.88e-05	0.000764	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTEN—head and neck cancer	3.88e-05	0.000763	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—DPYD—head and neck cancer	3.82e-05	0.000752	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—DPYD—head and neck cancer	3.79e-05	0.000746	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NAT2—head and neck cancer	3.69e-05	0.000727	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—YAP1—head and neck cancer	3.63e-05	0.000714	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—YAP1—head and neck cancer	3.6e-05	0.000708	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—DPYD—head and neck cancer	3.24e-05	0.000637	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—YAP1—head and neck cancer	3.07e-05	0.000605	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.96e-05	0.000583	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—head and neck cancer	2.79e-05	0.000549	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—head and neck cancer	2.73e-05	0.000538	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.7e-05	0.000532	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.58e-05	0.000509	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTEN—head and neck cancer	2.43e-05	0.000479	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TYMS—head and neck cancer	2.37e-05	0.000466	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.36e-05	0.000464	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.34e-05	0.000461	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.31e-05	0.000454	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPX1—head and neck cancer	2.24e-05	0.000441	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—head and neck cancer	2.23e-05	0.00044	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.22e-05	0.000437	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TYMS—head and neck cancer	2.18e-05	0.000429	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TYMS—head and neck cancer	2.16e-05	0.000425	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.15e-05	0.000424	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.13e-05	0.00042	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPX1—head and neck cancer	2.06e-05	0.000406	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPX1—head and neck cancer	2.04e-05	0.000402	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.04e-05	0.000402	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.02e-05	0.000398	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.01e-05	0.000396	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TYMS—head and neck cancer	1.85e-05	0.000363	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.82e-05	0.000359	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.82e-05	0.000359	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPX1—head and neck cancer	1.75e-05	0.000344	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.73e-05	0.00034	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—head and neck cancer	1.72e-05	0.000338	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.66e-05	0.000327	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.42e-05	0.00028	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—head and neck cancer	1.4e-05	0.000276	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.32e-05	0.00026	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.21e-05	0.000239	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.2e-05	0.000237	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTEN—head and neck cancer	1.15e-05	0.000227	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTEN—head and neck cancer	1.06e-05	0.000208	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTEN—head and neck cancer	1.05e-05	0.000207	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.03e-05	0.000202	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTEN—head and neck cancer	8.97e-06	0.000176	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—head and neck cancer	8.12e-06	0.00016	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—head and neck cancer	7.47e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.4e-06	0.000146	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—head and neck cancer	6.63e-06	0.000131	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—head and neck cancer	6.33e-06	0.000125	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—head and neck cancer	6.1e-06	0.00012	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—head and neck cancer	6.05e-06	0.000119	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—head and neck cancer	5.17e-06	0.000102	CbGpPWpGaD
